Biotech Pharma has been honored with the titles of "Top 100 Enterprises for High-Quality Development" and "Technology Innovation Enterprise"!-BIOTECH PHARMACEUTICAL CO., LTD_EGF Vaccine

Home
About Us
About Us

BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T
S&T

International-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
- Research Areas
- Technology Platforms
Research and Development
Research and Development

China has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
Blog
Blog

Integrating industry-related media coverage as well as the company’s various activities and updates.
- Company News
- Media Reports
Join Us
Join Us

Boasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
- Post-Doctoral Center
Contact Us
Contact Us

ThaiXinLife Consultation Hotline: +86 4006592330
Company Main Line: +86-10-51571020
- Contact Us

Biotech Pharma has been honored with the titles of "Top 100 Enterprises for High-Quality Development" and "Technology Innovation Enterprise"!

Category:

Company News

Author:

Source:

Release date:

2019-09-24

2019 Year 9 Month 19 On the day, the "Welcome National Day, Discussing Development Together" Entrepreneur Dialogue Meeting, hosted by the Beijing Municipal Committee of the Communist Party of China's Working Committee for the Economic and Technological Development Zone and the Beijing Economic-Technological Development Area Management Committee, was held grandly at the Yicheng Fortune Center in the development zone. Biotech Pharma was proudly honored with two prestigious awards from the Beijing Economic-Technological Development Area: the "Top 100 Enterprises for High-Quality Development" and the "Technology Innovation Enterprise." This recognition reflects the development zone's acknowledgment of the outstanding contributions made by all employees of Biotech Pharma, led by Mr. Bai Xianhong, to the growth of the economic zone. 27 Highly recognized for significant contributions to innovation, entrepreneurship, and driving development over the past year.